Renaissance Technologies’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.73M | Buy |
501,783
+4,400
| +0.9% | +$39.4K | 0.01% | 1503 |
|
|
2026
Q1 | $4.05M | Buy |
+497,383
| New | +$4.51M | 0.01% | 1490 |
|
|
2025
Q4 | – | Sell |
-1,196,750
| Closed | -$10.4M | – | 3592 |
|
|
2025
Q3 | $10.4M | Buy |
1,196,750
+529,103
| +79% | +$4.12M | 0.01% | 1082 |
|
|
2025
Q2 | $4.21M | Buy |
667,647
+162,400
| +32% | +$1.08M | 0.01% | 1637 |
|
|
2025
Q1 | $3.24M | Sell |
505,247
-902,283
| -64% | -$7.46M | ﹤0.01% | 1703 |
|
|
2024
Q4 | $11.3M | Sell |
1,407,530
-657,253
| -32% | -$6.34M | 0.02% | 945 |
|
|
2024
Q3 | $26.1M | Buy |
2,064,783
+954,600
| +86% | +$12.3M | 0.04% | 549 |
|
|
2024
Q2 | $14.1M | Buy |
+1,110,183
| New | +$11.2M | 0.02% | 754 |
|
|
2023
Q3 | – | Sell |
-438,883
| Closed | -$3.26M | – | 3958 |
|
|
2023
Q2 | $3.26M | Sell |
438,883
-3,101,500
| -88% | -$24.4M | ﹤0.01% | 1677 |
|
|
2023
Q1 | $24.5M | Buy |
3,540,383
+718,700
| +25% | +$6.61M | 0.03% | 616 |
|
|
2022
Q4 | $29M | Buy |
2,821,683
+1,941,100
| +220% | +$34.3M | 0.04% | 547 |
|
|
2022
Q3 | $16M | Buy |
+880,583
| New | +$38.2M | 0.02% | 786 |
|
|
2021
Q2 | – | Sell |
-672,683
| Closed | -$122M | – | 3683 |
|
|
2021
Q1 | $122M | Buy |
+672,683
| New | +$134M | 0.15% | 134 |
|
|
2020
Q4 | – | Sell |
-208,583
| Closed | -$22.6M | – | 3622 |
|
|
2020
Q3 | $22.6M | Buy |
+208,583
| New | +$25.4M | 0.02% | 684 |
|
|
2019
Q2 | – | Sell |
-120,883
| Closed | -$1.33M | – | 3701 |
|
|
2019
Q1 | $1.33M | Buy |
120,883
+99,685
| +470% | +$3.15M | ﹤0.01% | 2538 |
|
|
2018
Q4 | $780K | Buy |
+21,198
| New | +$822K | ﹤0.01% | 2692 |
|
|
2018
Q2 | – | Sell |
-289,323
| Closed | -$12.2M | – | 3449 |
|
|
2018
Q1 | $12.2M | Buy |
289,323
+148,545
| +106% | +$5.97M | 0.01% | 1243 |
|
|
2017
Q4 | $3.49M | Buy |
140,778
+5,280
| +4% | +$129K | ﹤0.01% | 2032 |
|
|
2017
Q3 | $3.09M | Buy |
135,498
+73,190
| +117% | +$1.64M | ﹤0.01% | 2060 |
|
|
2017
Q2 | $1.43M | Buy |
62,308
+46,865
| +303% | +$920K | ﹤0.01% | 2429 |
|
|
2017
Q1 | $395K | Sell |
15,443
-6,128
| -28% | -$169K | ﹤0.01% | 2839 |
|
|
2016
Q4 | $544K | Buy |
+21,571
| New | +$629K | ﹤0.01% | 2737 |
|
|
2015
Q4 | – | Sell |
-91,570
| Closed | -$12.9M | – | 3378 |
|
|
2015
Q3 | $12.9M | Buy |
91,570
+37,292
| +69% | +$8.36M | 0.03% | 759 |
|
|
2015
Q2 | $12.1M | Buy |
+54,278
| New | +$9.54M | 0.03% | 830 |
|
Other funds holding NVAX
SCM
S
Renaissance Technologies's NVAX Position: Q2 2026 in Review
Renaissance Technologies increased its Novavax (NVAX) stake by 0.88% in Q2 2026, buying an estimated $39.4K and bringing the position to 501,783 shares worth $4.73M. The position accounts for 0.01% of the portfolio, ranked #1503.
Renaissance Technologies first reported a position in NVAX in Q2 2015 and has held it in 24 quarters since. The position peaked at $122M in Q1 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Renaissance Technologies held 501,783 shares of Novavax worth $4.73M as of Q2 2026.
- Renaissance Technologies bought 4,400 Novavax shares in Q2 2026, an estimated $39.4K.
- Novavax made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1503 holding.
- Renaissance Technologies first reported a position in Novavax in Q2 2015 and has held it in 24 quarters since.
- Renaissance Technologies's Novavax position peaked at $122M in Q1 2021.
- 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.